{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:39:22Z","timestamp":1787009962701,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Activation of mast cells and systemic histamine release are major side effects of intravenously administered neuromuscular blocking agents (NMBAs). Mas-related G protein-coupled receptor-X2 (MRGPRX2) plays a key role in mediating anaphylactoid reactions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To explore the mechanism of acute anaphylactic shock induced by muscle relaxants through the typical shock cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DESIGN<\/jats:title>\n                    <jats:p>Case report and case control study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PATIENTS<\/jats:title>\n                    <jats:p>A 68-year-old male patient (80\u200akg) underwent surgical treatment in September 2023 and developed anaphylactic shock during anaesthesia induction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>A trial was conducted to evaluate the patient who experienced anaphylactic shock during the peri-operative period in comparison to control patients. The levels of MRGPRX2 and total immunoglobulin E (IgE) were measured in patient plasma, along with allergic mediators such as histamine and tryptase. Mast cell activation assay was performed to assess degranulation effectiveness by measuring \u03b2-hexosaminidase, histamine release, and calcium influx. Additionally, mast cell activation by peri-operative drugs was investigated. Local inflammatory experiments were conducted in a mouse model to evaluate rocuronium bromide-induced allergic reactions. Finally, MRGPRB2-CKO mice and siRNA silencing were used to elucidate the mechanism of rocuronium-induced anaphylactic shock.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      Plasma analysis of the patient experiencing anaphylaxis revealed normal total IgE levels (38.4\u200aIU\u200aml\n                      <jats:sup>\u22121<\/jats:sup>\n                      ) but significantly elevated histamine concentration (53.78\u200ang\u200aml\n                      <jats:sup>\u22121<\/jats:sup>\n                      ). The MRGPRX2 concentration (52.22\u200ang\u200aml\n                      <jats:sup>\u22121<\/jats:sup>\n                      ) in this patient was markedly higher than the negative control group (16.40\u200ang\u200aml\n                      <jats:sup>\u22121<\/jats:sup>\n                      ). Serum-activated mast cell assays demonstrated that the anaphylaxis patient's plasma induced a significant release of \u03b2-hexosaminidase, calcium, and histamine from mast cells (significantly higher than the histamine levels naturally present in the plasma). Drug-activated mast cell experiments confirmed that rocuronium bromide triggered dose-dependent mast cell activation, leading to MCP-1, histamine, and calcium release. Local paw oedema experiments in mice further validated that rocuronium bromide induced local allergic reactions. Using MRGPRB2-CKO mice and siRNA silencing, we determined that rocuronium bromide-induced anaphylactic shock was mediated through MRGPRX2 activation, resulting in mast cell degranulation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>This study highlights the critical role of MRGPRX2 in rocuronium bromide-induced anaphylactic shock. In vitro diagnosis of MRGPRX2 levels may provide new criteria for reducing intra-operative risks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TRIAL REGISTRATION<\/jats:title>\n                    <jats:p>The clinical trial was registered at the China Clinical Trial Registration Center (Registration Number: ChiCTR2300077364).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/eja.0000000000002256","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T16:00:14Z","timestamp":1758211214000},"page":"1074-1084","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["MRGPRX2 Triggers rocuronium bromide-induced peri-operative phase allergic shock"],"prefix":"10.1097","volume":"42","author":[{"given":"Zijun","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JianBo","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,17]]},"reference":[{"key":"R1-20251031","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/ALN.0000000000004419","article-title":"Perioperative anaphylaxis","volume":"138","author":"Tacquard","year":"2023","journal-title":"Anesthesiology"},{"key":"R2-20251031","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.iac.2021.09.002","article-title":"Perioperative anaphylaxis","volume":"42","author":"Pitlick","year":"2022","journal-title":"Immunol Allergy Clin North Am"},{"key":"R3-20251031","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1016\/j.bja.2019.01.027","article-title":"Comparative epidemiology of suspected perioperative hypersensitivity reactions","volume":"123","author":"Mertes","year":"2019","journal-title":"Br J Anaesth"},{"key":"R4-20251031","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11882-016-0598-5","article-title":"Mast cells and anaphylaxis","volume":"16","author":"Lieberman","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"R5-20251031","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1111\/bph.14332","article-title":"Regulation of vascular permeability in anaphylaxis","volume":"175","author":"Nakamura","year":"2018","journal-title":"Br J Pharmacol"},{"key":"R6-20251031","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1111\/all.13820","article-title":"An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactions","volume":"74","author":"Garvey","year":"2019","journal-title":"Allergy"},{"key":"R7-20251031","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaci.2021.02.013","article-title":"Mechanisms of human drug-induced anaphylaxis","volume":"147","author":"Bruhns","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"R8-20251031","doi-asserted-by":"crossref","first-page":"eaat1479","DOI":"10.1126\/scitranslmed.aat1479","article-title":"An IgG-induced neutrophil activation pathway contributes to human drug-induced anaphylaxis","volume":"11","author":"J\u00f6nsson","year":"2019","journal-title":"Sci Transl Med"},{"key":"R9-20251031","doi-asserted-by":"crossref","first-page":"1026304","DOI":"10.3389\/fimmu.2022.1026304","article-title":"Mas-related G protein-coupled receptor MRGPRX2 in human basophils: expression and functional studies","volume":"13","author":"Toscano","year":"2022","journal-title":"Front Immunol"},{"key":"R10-20251031","doi-asserted-by":"crossref","first-page":"668962","DOI":"10.3389\/fimmu.2021.668962","article-title":"Novel insights on MRGPRX2-mediated hypersensitivity to neuromuscular blocking agents and fluoroquinolones","volume":"12","author":"Elst","year":"2021","journal-title":"Front Immunol"},{"key":"R11-20251031","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2174\/138955712801264828","article-title":"The cyclodextrin sugammadex and anaphylaxis to rocuronium: is rocuronium still potentially allergenic in the inclusion complex form?","volume":"12","author":"Baldo","year":"2012","journal-title":"Mini Rev Med Chem"},{"key":"R12-20251031","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/2042098618769565","article-title":"Crowdsourcing sugammadex adverse event rates using an in-app survey: feasibility assessment from an observational study","volume":"9","author":"Jabaley","year":"2018","journal-title":"Ther Adv Drug Saf"},{"key":"R13-20251031","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3390\/cells10010156","article-title":"MRGPRX2 activation by rocuronium: insights from studies with human skin mast cells and missense variants","volume":"10","author":"Chompunud Na Ayudhya","year":"2021","journal-title":"Cells"},{"key":"R14-20251031","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1016\/j.bja.2019.01.031","article-title":"Molecular mechanisms and pathophysiology of perioperative hypersensitivity and anaphylaxis: a narrative review","volume":"123","author":"Ebo","year":"2019","journal-title":"Br J Anaesth"},{"key":"R15-20251031","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.jaip.2019.11.018","article-title":"Anaphylaxis to sugammadex-rocuronium inclusion complex: an IgE-mediated reaction due to allergenic changes at the sugammadex primary rim","volume":"8","author":"Ebo","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R16-20251031","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13601-020-00361-8","article-title":"A novel ELISA method to determine human MrgX2 in chronic urticaria","volume":"10","author":"Ding","year":"2020","journal-title":"Clin Transl Allergy"},{"key":"R17-20251031","doi-asserted-by":"crossref","first-page":"13714","DOI":"10.1038\/s41598-017-14224-z","article-title":"Use of the relative release index for histamine in LAD2 cells to evaluate the potential anaphylactoid effects of drugs","volume":"7","author":"Han","year":"2017","journal-title":"Sci Rep"},{"key":"R18-20251031","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/WOX.0b013e318211496c","article-title":"World allergy organization guidelines for the assessment and management of anaphylaxis","volume":"4","author":"Simons","year":"2011","journal-title":"World Allergy Organ J"},{"key":"R19-20251031","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.2147\/JIR.S480644","article-title":"Quercetin attenuates MRGPRX2-mediated mast cell degranulation via the MyD88\/IKK\/NF-\u03baB and PI3K\/AKT\/Rac1\/Cdc42 pathway","volume":"17","author":"Zhao","year":"2024","journal-title":"J Inflamm Res"},{"key":"R20-20251031","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/cells13010093","article-title":"The underlying Rab network of MRGPRX2-stimulated secretion unveils the impact of receptor trafficking on secretory granule biogenesis and secretion","volume":"13","author":"Lazki-Hagenbach","year":"2024","journal-title":"Cells"},{"key":"R21-20251031","doi-asserted-by":"crossref","first-page":"892239","DOI":"10.3389\/fimmu.2022.892239","article-title":"Spatiotemporal patterns of substance P-bound MRGPRX2 reveal a novel connection between macropinosome resolution and secretory granule regeneration in mast cells","volume":"13","author":"Lazki-Hagenbach","year":"2022","journal-title":"Front Immunol"},{"key":"R22-20251031","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jaip.2018.01.004","article-title":"In vitro diagnosis of immediate drug hypersensitivity during anesthesia: a review of the literature","volume":"6","author":"Ebo","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R23-20251031","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.jaip.2017.12.037","article-title":"Comparison of basophil activation test and skin testing performances in NMBA allergy","volume":"6","author":"Dewachter","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R25-20251031","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/all.12142","article-title":"Skin test concentrations for systemically administered drugs \u2013 an ENDA\/EAACI Drug Allergy Interest Group position paper","volume":"68","author":"Brockow","year":"2013","journal-title":"Allergy"},{"key":"R26-20251031","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1016\/j.bja.2019.01.035","article-title":"Use of simulation to improve management of perioperative anaphylaxis: a narrative review","volume":"123","author":"Kolawole","year":"2019","journal-title":"Br J Anaesth"},{"key":"R27-20251031","doi-asserted-by":"crossref","first-page":"615236","DOI":"10.3389\/fimmu.2020.615236","article-title":"Interleukin-33 amplifies human mast cell activities induced by complement anaphylatoxins","volume":"11","author":"West","year":"2020","journal-title":"Front Immunol"},{"key":"R28-20251031","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/ALN.0000000000000516","article-title":"Anaphylaxis to neuromuscular-blocking drugs: all neuromuscular-blocking drugs are not the same","volume":"122","author":"Mertes","year":"2015","journal-title":"Anesthesiology"},{"key":"R29-20251031","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/13497413.2018.1481580","article-title":"Rocuronium anaphylaxis in a 7-year-old boy during the induction of anesthesia","volume":"41","author":"Morimoto","year":"2018","journal-title":"Immunol Med"},{"key":"R30-20251031","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4097\/kjae.2010.59.6.411","article-title":"Rocuronium bromide induced anaphylaxis in a child \u2013 a case report","volume":"59","author":"Jang","year":"2010","journal-title":"Korean J Anesthesiol"},{"key":"R31-20251031","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature14022","article-title":"Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions","volume":"519","author":"McNeil","year":"2015","journal-title":"Nature"}],"container-title":["European Journal of Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/EJA.0000000000002256","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:00:14Z","timestamp":1761901214000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/EJA.0000000000002256"}},"subtitle":["A case report with case control study"],"short-title":[],"issued":{"date-parts":[[2025,9,17]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/eja.0000000000002256","relation":{},"ISSN":["0265-0215","1365-2346"],"issn-type":[{"value":"0265-0215","type":"print"},{"value":"1365-2346","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,17]]},"assertion":[{"value":"2025-02-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}